On July 9, Aspire Biopharma Holdings announced positive initial consumer feedback for its new sublingual pre-workout supplement, called BUZZ BOMB.

Simtra BioPharma Solutions purchased a 65-acre property in Monroe County, Indiana, from Cook Group to expand its operations. The expansion may include the production of cancer drugs, responding to ...

By Adriano Marchese Biopharmaceutical company Quantum BioPharma said it has acquired 2,000 shares of specialty games and entertainment retailer GameStop in what it calls a strategic investment.

SOUTH SAN FRANCISCO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody ...

Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World Written by aspire biopharma holdings inc.

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said ...

Yet another biopharma name has been run through a familiar trading cycle that often ends on a bullish note.

Layoffs in biopharma show no signs of slowing, with workforce reductions holding steady across the first two quarters of 2025. | Biopharma layoffs have held steady through mid-2025, and in this ...

Biopharma companies raised $7.38 billion across 99 transactions in June 2025, up from $5.55 billion in May and $2.4 billion in April. For the first half of the year (H1), total financings reached ...

ArriVent BioPharma aims to raise $75 million in a public stock sale, using the proceeds to advance its lung cancer drug and other pipeline programs.

Argon AI Inc., the developer of an artificial intelligence-native workspace platform purpose-built for life sciences, today announced it has raised $5.5 million in seed funding to bring insights ...

Proposed cuts will have “a catastrophic effect on the advancement of biomedical and biotechnology capabilities in the United States,” more than 100 leaders of biomedical/health sciences ...